Citadel Advisors
MDXG icon

Citadel Advisors’s MiMedx Group MDXG Stock Holding History

Citadel Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,200
Closed -$71.2K – 13515
2025
Q3 		$71.2K Buy
+10,200
New +$70.9K ﹤0.01% 12026
2025
Q2 		– Sell
-7,200
Closed -$54.7K – 14043
2025
Q1 		$54.7K Buy
7,200
+800
+13% +$6.68K ﹤0.01% 12219
2024
Q4 		$61.6K Sell
6,400
-1,600
-20% -$12.5K ﹤0.01% 12151
2024
Q3 		$47.3K Sell
8,000
-26,600
-77% -$176K ﹤0.01% 11971
2024
Q2 		$240K Sell
34,600
-68,100
-66% -$479K ﹤0.01% 9566
2024
Q1 		$791K Buy
102,700
+13,200
+15% +$106K ﹤0.01% 7419
2023
Q4 		$785K Buy
89,500
+56,400
+170% +$413K ﹤0.01% 7173
2023
Q3 		$241K Sell
33,100
-4,000
-11% -$29.8K ﹤0.01% 9560
2023
Q2 		$245K Buy
37,100
+23,600
+175% +$120K ﹤0.01% 9441
2023
Q1 		$46K Sell
13,500
-1,900
-12% -$7.36K ﹤0.01% 12264
2022
Q4 		$42.8K Sell
15,400
-9,500
-38% -$28.4K ﹤0.01% 12321
2022
Q3 		$71K Sell
24,900
-29,000
-54% -$103K ﹤0.01% 11371
2022
Q2 		$187K Buy
53,900
+8,700
+19% +$34.1K ﹤0.01% 10769
2022
Q1 		$213K Sell
45,200
-9,800
-18% -$47.9K ﹤0.01% 11375
2021
Q4 		$332K Sell
55,000
-36,300
-40% -$252K ﹤0.01% 10705
2021
Q3 		$553K Buy
91,300
+39,100
+75% +$441K ﹤0.01% 9620
2021
Q2 		$653K Buy
52,200
+21,200
+68% +$230K ﹤0.01% 9407
2021
Q1 		$319K Buy
31,000
+20,300
+190% +$196K ﹤0.01% 10711
2020
Q4 		$97K Buy
+10,700
New +$77K ﹤0.01% 10239
2018
Q4 		– Sell
-215,300
Closed -$1.33M – 9506
2018
Q3 		$1.33M Sell
215,300
-66,300
-24% -$300K ﹤0.01% 5062
2018
Q2 		$1.8M Buy
281,600
+119,300
+74% +$849K ﹤0.01% 4269
2018
Q1 		$1.13M Buy
162,300
+2,800
+2% +$32.6K ﹤0.01% 4645
2017
Q4 		$2.01M Buy
159,500
+123,400
+342% +$1.5M ﹤0.01% 3622
2017
Q3 		$429K Buy
36,100
+19,100
+112% +$283K ﹤0.01% 5545
2017
Q2 		$254K Buy
+17,000
New +$227K ﹤0.01% 6187
2016
Q2 		– Sell
-16,300
Closed -$142K – 7160
2016
Q1 		$142K Buy
16,300
+9,600
+143% +$79.8K ﹤0.01% 5862
2015
Q4 		$63K Sell
6,700
-9,300
-58% -$80.6K ﹤0.01% 7122
2015
Q3 		$154K Buy
16,000
+300
+2% +$3.17K ﹤0.01% 6480
2015
Q2 		$182K Buy
15,700
+12,600
+406% +$130K ﹤0.01% 6438
2015
Q1 		$32K Sell
3,100
-17,800
-85% -$167K ﹤0.01% 7658
2014
Q4 		$241K Buy
20,900
+17,900
+597% +$177K ﹤0.01% 5744
2014
Q3 		$21K Sell
3,000
-100
-3% -$697 ﹤0.01% 7391
2014
Q2 		$22K Buy
+3,100
New +$18.1K ﹤0.01% 7235

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors's MDXG Position: Q1 2026 in Review

Citadel Advisors increased its MiMedx Group (MDXG) stake by 73% in Q1 2026, buying an estimated $1.65M and bringing the position to 776,441 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #5221.

Citadel Advisors first reported a position in MDXG in Q3 2013 and has held it in 36 quarters since. The position peaked at $4.47M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Citadel Advisors held 776,441 shares of MiMedx Group worth $3.07M as of Q1 2026.
  • Citadel Advisors bought 326,779 MiMedx Group shares in Q1 2026, an estimated $1.65M.
  • MiMedx Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5221 holding.
  • Citadel Advisors first reported a position in MiMedx Group in Q3 2013 and has held it in 36 quarters since.
  • Citadel Advisors's MiMedx Group position peaked at $4.47M in Q3 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.